Biocon Archives - Express Pharma

Biocon and Equillium expand exclusive licensing agreement for Itolizumab to include Australia and New Zealand

Biocon appoints Siddharth Mittal as its CEO and Joint MD

USFDA approves Biocon’s sBLA for Pegfilgrastim new manufacturing facility

ICMR honours Kiran Mazumdar-Shaw with Lifetime Achievement Award

Biocon features in the ASIA IP ELITE list for the fourth consecutive year

Biocon moves up to rank no 6 on Science Careers’ top 20 global pharma and biotech employers list 2019

Biocon announces Q2FY20 Earnings

Biocon Biologics, Just – Evotec Biologics ink licensing pact for biosimilar asset

Biocon, Mylan launch insulin biosimilar in Australia

Biocon subsidiary acquires research facility from Pfizer Healthcare